[Google Scholar] [25].Adlyxin (lixisenatide) injection, for subcutaneous use [prescribing information]
On the path to patients, NASH drugs may hit a payer roadblock
Has been successful in stimulating patients who plateaued on medication, and we have found that adding it to their regimen successfully helped kick start their loss again more times than not
This distinction is critical when discussing risk with patients who already have hypertension, coronary artery disease, or heart failure
Although the reduction in risk for HS complications was not as large among those with type 2 diabetes, researchers observed similar reductions in the rates of surgeries (HR = 0.25
If you're sensitive to caffeine or have been advised to avoid stimulants, this may be relevant